1. Volume 83, Issue 2, Pages 300-307 (February 2013)
A multinational cohort study of in-center daily hemodialysis and patient survival 
Rita S. Suri, Robert M. Lindsay, Brian A. Bieber, Ronald L. Pisoni, Amit X. Garg, Peter C. Austin, Louise M. Moist, Bruce M. Robinson, Brenda W. Gillespie, Cecile G. Couchoud, Roula Galland, Eduardo K. Lacson, Deborah L. Zimmerman, Yun Li, Gihad E. Nesrallah 
Kidney International 
Volume 83, Issue 2, Pages (February 2013)
DOI: /ki
Copyright © 2013 International Society of Nephrology Terms and Conditions

2. Figure 1
Selection of the study sample. aPatients missing data for any of the following comorbid conditions were excluded: diabetes, myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, and cancer. All the 88 patients who were excluded on this basis were from France. bBecause there were no patients with dementia or cancer in the United States receiving daily dialysis, patients with dementia and cancer were excluded from the conventional dialysis group in the United States only. cThe index date refers to the date a patient was registered in the database; follow-up began after this date. dFor France only. ESRD, end-stage renal disease.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions

3. Figure 2
Cumulative survival with daily versus conventional hemodialysis (n=893, matched sample).
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions

4. Figure 3
Hazard ratio of death with daily versus conventional hemodialysis in various subgroups. *The median age was 57, 69, and 40 years in France, Canada, and USA, respectively. **The median vintage was 3.7, 4.7, and 2.7 years in France, Canada, and USA, respectively. CI, confidence interval; Conv, conventional hemodialysis; HR, hazard ratio.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions